Research Desk Line-up: Marrone Bio Innovations Post Earnings Coverage
LONDON, UK / ACCESSWIRE / September 11, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Agrium Inc. (NYSE: AGU), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=AGU, following the Company's release of its financial results on August 9, 2017 for the second quarter fiscal 2017. The Company's EBITDA increased 1.7% on a y-o-y basis. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member's account at:
Get more of our free earnings reports coverage from other constituents of the Agricultural Chemicals industry. Pro-TD has currently selected Marrone Bio Innovations, Inc. (NASDAQ: MBII) for due-diligence and potential coverage as the Company provided on August 14, 2017, its financial results for Q2 2017 which ended on June 30, 2017. Register for a free membership today, and be among the early birds that get access to our report on Marrone Bio Innovations when we publish it.
At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on AGU; also brushing on MBII. With the links below you can directly download the report of your stock of interest-free of charge at:
For three months ended June 30, 2017, Agrium's revenue decreased 1% on a y-o-y basis to $6.32 billion from $6.42 billion in Q2 FY16. The revenue surpassed analysts' expectations of $6.19 billion.
During Q2 FY17, the Company's gross profit was $1.53 billion, at par with $1.53 billion in Q2 FY16. For the reported quarter, the Company's selling, general, and administrative expenses (SG&A) were $636 million, at par with $636 million in Q2 FY16. During Q2 FY17, Agrium's EBITDA increased 1.7% to $1.01 billion from $993 million in Q2 FY16.
For the reported quarter, Agrium's effective tax rate was 28.5% compared to 27.5% in Q2 FY16.
During Q2 FY17, Agrium's net income decreased 1.2% to $558 million on a y-o-y basis from $565 million in Q2 FY16. For the reported quarter, the Company's diluted EPS decreased 1.2% to $4.03 on a y-o-y basis from $4.08 in Q2 FY16. During Q2 FY17, the Company's adjusted diluted EPS decreased 2.2% to $4.09 on a y-o-y basis from $4.18 in Q2 FY16. The adjusted EPS surpassed analysts' expectations of $4.04.
On August 10, 2017, the Company's Board of Directors declared a dividend of $0.88 payable on October 19, 2017, to shareholders of record as on September 29, 2017.
Agrium's Segment Details
Retail - During Q2 FY17, the Retail segment's revenue decreased 1.4% to $5.71 billion from $5.79 billion in Q2 FY16. The decrease was due to lower crop nutrient prices. During Q2 FY17, the segment's Crop Nutrients revenue decreased 9% to $1.99 billion on a y-o-y basis and crop Protection Products' revenue remained almost flat at $2.24 billion. For the reported quarter, the segment's gross profit increased 1.6% to $1.30 billion from $1.28 billion in Q2 FY16. During Q2 FY17, the segment's EBIT increased 3.6% to $700 million from $676 million in Q2 FY16. The segment's EBITDA increased 3.6% to $771 million in Q2 FY17 from $744 million in Q2 FY16.
Wholesale - During Q2 FY17, the Wholesale segment's revenue decreased 3.9% to $848 million from $882 million in Q2 FY16. During Q2 FY17, the segment's Nitrogen's revenue decreased 1% to $368.47 million on a y-o-y basis. For the reported quarter, the segment's gross profit decreased 2.5% to $196 million from $201 million in Q2 FY16. During Q2 FY17, the segment's EBIT decreased 2.8% to $175 million from $180 million in Q2 FY16. For the reported quarter, the segment's EBITDA increased 39 basis points to $255 million from $254 million in Q2 FY16.
As on June 30, 2017, Agrium's cash and cash equivalents decreased 23% to $319 million from $412 million in Q4 FY16.
During Q2 FY17, the Company's inventories decreased 12% to $2.85 billion from $3.23 billion in Q4 FY16.
During Q2 FY17, Agrium's accounts payable decreased 11% to $4.16 billion from $4.66 billion in Q4 FY16.
During Q2 FY17, the Company's long-term debt was $4.40 billion compared to $4.41 billion in Q2 FY16.
For the reported quarter, the Company's cash provided by operating activities was negative $115 million compared to positive $95 million in Q2 FY16.
For FY17, Agrium expects diluted EPS to be in the range of $4.75-$5.25 and expects tax rate to be in the range of 27%-29%.
The Company estimates capital expenditure to be in the range of $650 million-$700 million.
Agrium's share price finished last Friday's trading session at $99.76, slightly advancing 0.02%. A total volume of 151.75 thousand shares have exchanged hands. The Company's stock price advanced 5.07% in the last three months, 2.33% in the past six months, and 3.83% in the previous twelve months. Shares of the Company have a PE ratio of 24.03 and have a dividend yield of 3.51%. The stock currently has a market cap of $13.64 billion.
Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: (917) 341.4653
Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Pro-Trader Daily